Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Intervalo de año de publicación
1.
Oncologist ; 23(4): 422-432, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29330208

RESUMEN

BACKGROUND: Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are a complex family of tumors of widely variable clinical behavior. The World Health Organization (WHO) 2010 classification provided a valuable tool to stratify neuroendocrine neoplasms (NENs) in three prognostic subgroups based on the proliferation index. However, substantial heterogeneity remains within these subgroups, and simplicity sometimes entails an ambiguous and imprecise prognostic stratification. The purpose of our study was to evaluate the prognostic impact of histological differentiation within the WHO 2010 grade (G) 1/G2/G3 categories, and explore additional Ki-67 cutoff values in GEP-NENs. SUBJECTS, MATERIALS, AND METHODS: A total of 2,813 patients from the Spanish National Tumor Registry (RGETNE) were analyzed. Cases were classified by histological differentiation as NETs (neuroendocrine tumors [well differentiated]) or NECs (neuroendocrine carcinomas [poorly differentiated]), and by Ki-67 index as G1 (Ki-67 <2%), G2 (Ki-67 3%-20%), or G3 (Ki-67 >20%). Patients were stratified into five cohorts: NET-G1, NET-G2, NET-G3, NEC-G2, and NEC-G3. RESULTS: Five-year survival was 72%. Age, gender, tumor site, grade, differentiation, and stage were all independent prognostic factors for survival. Further subdivision of the WHO 2010 grading improved prognostic stratification, both within G2 (5-year survival: 81% [Ki-67 3%-5%], 72% [Ki-67 6%-10%], 52% [Ki-67 11%-20%]) and G3 NENs (5-year survival: 35% [Ki-67 21%-50%], 22% [Ki-67 51%-100%]). Five-year survival was significantly greater for NET-G2 versus NEC-G2 (75.5% vs. 58.2%) and NET-G3 versus NEC-G3 (43.7% vs. 25.4%). CONCLUSION: Substantial clinical heterogeneity is observed within G2 and G3 GEP-NENs. The WHO 2010 classification can be improved by including the additive effect of histological differentiation and the proliferation index. IMPLICATIONS FOR PRACTICE: Gastroenteropancreatic neuroendocrine neoplasms are tumors of widely variable clinical behavior, roughly stratified by the World Health Organization (WHO) 2010 classification into three subgroups based on proliferation index. Real-world data from 2,813 patients of the Spanish Registry RGETNE demonstrated substantial clinical heterogeneity within grade (G) 2 and G3 neuroendocrine neoplasms. Tumor morphology and further subdivision of grading substantially improves prognostic stratification of these patients and may help individualize therapy. This combined, additive effect shall be considered in future classifications of neuroendocrine tumors and incorporated for stratification purposes in clinical trials.


Asunto(s)
Carcinoma Neuroendocrino/clasificación , Carcinoma Neuroendocrino/patología , Neoplasias Intestinales/clasificación , Neoplasias Intestinales/patología , Tumores Neuroendocrinos/clasificación , Tumores Neuroendocrinos/patología , Neoplasias Pancreáticas/clasificación , Neoplasias Pancreáticas/patología , Sistema de Registros/estadística & datos numéricos , Neoplasias Gástricas/clasificación , Neoplasias Gástricas/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Neuroendocrino/metabolismo , Carcinoma Neuroendocrino/mortalidad , Diferenciación Celular , Niño , Femenino , Humanos , Neoplasias Intestinales/metabolismo , Neoplasias Intestinales/mortalidad , Antígeno Ki-67/metabolismo , Masculino , Persona de Mediana Edad , Clasificación del Tumor , Estadificación de Neoplasias , Tumores Neuroendocrinos/metabolismo , Tumores Neuroendocrinos/mortalidad , Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/mortalidad , Pronóstico , Modelos de Riesgos Proporcionales , España , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/mortalidad , Tasa de Supervivencia , Organización Mundial de la Salud , Adulto Joven
2.
Biopreserv Biobank ; 16(2): 128-137, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29369693

RESUMEN

The conservation of microorganisms is essential for their in-depth study. However, today's most widely used conservation methods, based on the use of distilled water, soil, oils, or silica, do not guarantee the stability of fungal cells, especially dermatophytes. This problem led us to evaluate the conservation capacity of a cryogenic vials system containing glass beads covered in a cryopreservant hypertonic solution as an alternative method of storage of fungal cells at -80°C. Up to 570 strains of fungi belonging to 27 different species, isolated from clinical samples, were inoculated into cryotubes containing 25 glass beads covered in a cryopreserving hypertonic solution. Suspensions were mixed vigorously and the cryopreserving solution was discarded. The tubes were frozen at -80°C for a period of 42 months and periodically, a glass bead was removed from each cryotube and inoculated onto Sabouraud dextrose agar, and incubated at 30°C for 7-14 days to evaluate the number of colonies recovered, their purity, and phenotypic characteristics. All yeast isolates were recovered, unlike 2 isolates (4.4%) of the mold group and 21 (10.7%) of the dermatophytes. Survival rates were close to 100% for yeasts and molds, with expiration times being estimated for almost indefinite stocks, and 62% for dermatophytes, with an average expiration date of 25.5 years. The phenotypic characteristics remained comparable to those of the strains before storage. Conservation at -80°C using cryogenic vials is a reliable and efficient system for the conservation of fungal collections, and although the behavior differs by groups, stratified survival data are obtained to avoid extinction.


Asunto(s)
Arthrodermataceae/citología , Criopreservación/métodos , Arthrodermataceae/metabolismo , Humanos , Factores de Tiempo
3.
Cir Cir ; 80(1): 44-51, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22472152

RESUMEN

BACKGROUND: Gastrointestinal stromal tumors (GIST) are the most common mesenchymal neoplasms of the digestive tract. They originate from the interstitial cells of Cajal and are characterized by the overexpression of KIT protein (tyrosine kinase). Their prognosis has improved significantly with the discovery of imatinib mesylate for advanced GIST treatment. METHODS: We carried out a retrospective, descriptive study of GISTs diagnosed in our center during the past 5 years. We excluded patients with incidental diagnoses in the context of other pathologies because GIST did not affect outcome or prognosis. The variables studied were clinical characteristics, location, size, imaging techniques, resectability, neoadjuvant imatinib, surgical technique, histology, immunohistochemistry, prognostic classification of Fletcher, morbidity, monitoring, and disease-free and overall survival. RESULTS: Nineteen patients were diagnosed (14 males/5 females) with a mean age of 63 years (range: 30-84 years). Diagnosis was incidental in eight patients (42%). Tumor location of the remaining 11 patients (58%) was six tumors of the small intestine (55%), four gastric (36%) and one rectal (9%). Predominant gastrointestinal bleeding and anemia were diagnosed mainly by abdominal computed tomography (CT). At diagnosis, nine patients were considered resectable with radical intent (82%) and the other two patients (18%) received neoadjuvant treatment with a favorable response after 6 months. Three patients were treated with imatinib after surgery (33%). Median survival was 34 months (range: 5-58 months). CONCLUSIONS: Diagnosis of GIST is often incidental. The predominant clinical symptom is usually gastrointestinal bleeding and anemia and the most widely used imaging test is CT. Treatment is surgical unless advanced GIST is diagnosed, which will be treated with imatinib mesylate neoadjuvant therapy. A multidisciplinary approach to this pathology is essential, a fact that affects prognosis and patient survival.


Asunto(s)
Neoplasias Gastrointestinales/diagnóstico , Neoplasias Gastrointestinales/cirugía , Tumores del Estroma Gastrointestinal/diagnóstico , Tumores del Estroma Gastrointestinal/cirugía , Adenocarcinoma/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Anemia/etiología , Anemia/terapia , Antineoplásicos/uso terapéutico , Benzamidas , Biomarcadores de Tumor/análisis , Transfusión Sanguínea , Terapia Combinada , Diagnóstico por Imagen/métodos , Hemorragia Gastrointestinal/etiología , Neoplasias Gastrointestinales/tratamiento farmacológico , Neoplasias Gastrointestinales/epidemiología , Neoplasias Gastrointestinales/genética , Tumores del Estroma Gastrointestinal/tratamiento farmacológico , Tumores del Estroma Gastrointestinal/epidemiología , Tumores del Estroma Gastrointestinal/genética , Hernia Inguinal/complicaciones , Humanos , Mesilato de Imatinib , Hallazgos Incidentales , Persona de Mediana Edad , Terapia Neoadyuvante , Neoplasias Primarias Múltiples/cirugía , Piperazinas/uso terapéutico , Pirimidinas/uso terapéutico , Estudios Retrospectivos , Neoplasias Gástricas/cirugía , Análisis de Supervivencia , Tomografía Computarizada por Rayos X
5.
Prog. obstet. ginecol. (Ed. impr.) ; 49(9): 479-484, sept. 2006. tab
Artículo en Es | IBECS | ID: ibc-048485

RESUMEN

Objetivo: Comparar los resultados de la cirugía del quiste dermoide de ovario (quistectomía, ooforectomía y anexectomía) mediante laparotomía y laparoscopia, especialmente relacionados con las complicaciones (rotura del quiste). Sujetos y métodos: Estudio analítico, descriptivo y retrospectivo de 91 casos de quistes dermoides operados en el Hospital Severo Ochoa de Madrid entre enero de 2001 y diciembre de 2004. Los casos se recogieron de la base de datos del servicio de anatomía patológica, los datos de éstos, de la revisión de las historias clínicas de las pacientes, y los resultados se analizaron estadísticamente mediante el paquete informático EpiInfo versión 6.0. Resultados: El 79% de las intervenciones realizadas por laparoscopia, igual tasa de complicaciones, igual riesgo de rotura del quiste en casos de quistectomía, menor estancia media en el acceso laparoscópico, menor duración de la intervención por laparotomía en casos de ooforectomía/anexectomía. Conclusiones: El tratamiento quirúrgico mediante acceso laparoscópico de los quistes dermoides de ovario es seguro, no aumenta la tasa de complicaciones y permite disminuir la estancia media. Durante la realización de la quistectomía el riesgo de rotura del quiste es igual por laparoscopia que por laparotomía


Objective: To compare the results of laparoscopy and laparotomy in teh treatment of ovarian dermoid cysts (cystectomy, oophorectomy and adenectomy, mainly those related with complications (intraoperative spillage). Subjects and methods: We analize retrospectively a case series of 91 patients with dermoid cysts treated al Hospital Severo Ochoa in Madrid, from January 2001 to Decembre 2004. Data were obtained from the pathology register and from the hospital charts, and were analized with the software EpiInfo 6.0 version. Results: 79% laparoscopic approaches, same complications rate, same intraoperative spillage risk, lower hospital stay in laparoscopic group, lower operating time in case of oophorectomy/anexectomy by laparotomy. Conclusions: Laparoscopic management of ovarian teratomas is as safe as laparotomic one. The same complications rate is observed in both groups, and lower hospital stay is achieved in laparoscopic surgery. If cystectomy is recommended intraoperative spillage risk should not contraindicate laparoscopy


Asunto(s)
Femenino , Humanos , Quiste Dermoide/cirugía , Laparoscopía/métodos , Laparotomía/métodos , Quistes Ováricos/cirugía , Estudios Retrospectivos , Rotura/epidemiología , Complicaciones Intraoperatorias/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA